Neural Analytics CEO and leadership

Diane Bryant is as an independent director and member of the compensation committee at Broadcom Inc. Prior, she was the chief operating officer of the Google Cloud Platform and she previously served as the group president of Intel's data center group.

As Chief Scientific Officer of Neural Analytics Inc., my main role is to advance our proprietary technology to different segments of brain health management. Neural Analytics is initially focused on the diagnosis and management of traumatic brain injury with additional applications that span all types of neurological diseases and injuries. I current work with clinicians and researchers around the world to develop clinical trial designs to extend the use of our technology.

UPDATE: Neural Analytics received FDA clearance on their first product

Javad brings to Neural Analytics 30 years of experience improving quality systems, process efficiency, regulatory compliance, product cost and organizational design, by establishing operational excellence through teamwork, lean six sigma and customer driven quality interaction. Javad served as Global Senior Vice President of Quality Assurance and Regulatory Affairs at Gambro AB. He has extensive knowledge and experience from the QA/RA arena, having operated globally for many years within the medical and diagnostic industry. Prior to joining Gambro, he was the Senior Vice President of Siemens Medical Solutions Diagnostics Division, where he was responsible for global Quality Assurance, Regulatory Affairs, Quality Systems, Health Environment and Safety, Reimbursement and Government Affairs, Medical and Clinical Affairs, and Biostatistics. He also served as a member of the Siemens Medical Solutions Diagnostics Management Group. Prior to joining Siemens, Mr. Seyedzadeh led the Quality and Regulatory functions at Bayer Diagnostics and Toshiba, where he helped create an innovative, worldwide quality management system-encompassing more than fifteen sites in forty-four countries-that made the division an industry leader. Mr. Seyedzadeh serves as a Director of JS Genetics, Inc. He is an advisor to the Food and Drug Administration’s Office of Diagnostics Devices Evaluation and sits on the ADVAMED advisory group.

As Chief Scientific Officer of Neural Analytics Inc., my main role is to advance our proprietary technology to different segments of brain health management. Neural Analytics is initially focused on the diagnosis and management of traumatic brain injury with additional applications that span all types of neurological diseases and injuries. I current work with clinicians and researchers around the world to develop clinical trial designs to extend the use of our technology.

UPDATE: Neural Analytics received FDA clearance on their first product